Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Hyderabad Eye Research Foundation (HERF) serves as the translational research arm of the L. V. Prasad Eye Institute (LVPEI), focusing on the molecular biology, genetics, and treatment of ocular diseases. HERF is globally recognized for its pioneering work in regenerative medicine, particularly the development of Simple Limbal Epithelial Transplantation (SLET) for treating corneal blindness. The foundation conducts extensive research into the genetic basis of glaucoma and corneal dystrophies, utilizing advanced proteomics and genomics to identify novel therapeutic targets. By integrating basic science with clinical practice, HERF aims to develop affordable and scalable solutions for visual impairment prevalent in developing nations. Its facilities include state-of-the-art laboratories for stem cell biology, ocular microbiology, and ophthalmic pathology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hyderabad Eye Research Foundation.